A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Several Kentucky bills filed this legislative session have one thing in common: a shared skepticism of guidance from top U.S.

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...